In prostate cancer, high IL-7 expression correlates with poor prognosis because IL-7R activation promotes invasion and migration via the AKT/NF-κB pathway and matrix metalloproteinase (MMP) regulation [51,52]. This evidence concerns the gene IL7 and Familial prostate cancer.